Megesterol: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
Line 17: Line 17:
[[Category:Oncology]]
[[Category:Oncology]]


{{SIB}}
 
{{WH}}
{{WH}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 17:17, 9 August 2012

WikiDoc Resources for Megesterol

Articles

Most recent articles on Megesterol

Most cited articles on Megesterol

Review articles on Megesterol

Articles on Megesterol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Megesterol

Images of Megesterol

Photos of Megesterol

Podcasts & MP3s on Megesterol

Videos on Megesterol

Evidence Based Medicine

Cochrane Collaboration on Megesterol

Bandolier on Megesterol

TRIP on Megesterol

Clinical Trials

Ongoing Trials on Megesterol at Clinical Trials.gov

Trial results on Megesterol

Clinical Trials on Megesterol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Megesterol

NICE Guidance on Megesterol

NHS PRODIGY Guidance

FDA on Megesterol

CDC on Megesterol

Books

Books on Megesterol

News

Megesterol in the news

Be alerted to news on Megesterol

News trends on Megesterol

Commentary

Blogs on Megesterol

Definitions

Definitions of Megesterol

Patient Resources / Community

Patient resources on Megesterol

Discussion groups on Megesterol

Patient Handouts on Megesterol

Directions to Hospitals Treating Megesterol

Risk calculators and risk factors for Megesterol

Healthcare Provider Resources

Symptoms of Megesterol

Causes & Risk Factors for Megesterol

Diagnostic studies for Megesterol

Treatment of Megesterol

Continuing Medical Education (CME)

CME Programs on Megesterol

International

Megesterol en Espanol

Megesterol en Francais

Business

Megesterol in the Marketplace

Patents on Megesterol

Experimental / Informatics

List of terms related to Megesterol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Megestrol is an appetite enhancing drug used to aid chemotherapy and HIV/AIDS patients gain mass. Little is known about the drug's chemical interactions. Doses Ranges from 80 mg po tid, 30 minutes before meals, to 800 mg po qd. Side effects may include diarrhea, rash, impotence, males may have some feminizing effects such as gynecomastia (breast development). It is a category X FDA drug, which means cannot be used in pregnancy as it crosses the placenta and malignantly affects the fetus.

References

1) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=12816553&ordinalpos=9&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

2) http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=15064933&dopt=Abstract

3) http://www.hivdent.org/drugs/MEGESTEROL.htm


Template:WH Template:WikiDoc Sources